USANA Health Sciences, Inc.
General ticker "USNA" information:
- Sector: Consumer Staples
- Industry: Packaged Foods
- Capitalization: $373.1M (TTM average)
USANA Health Sciences, Inc. does not follow the US Stock Market performance with the rate: -8.9%.
Estimated limits based on current volatility of 1.6%: low 14.81$, high 15.27$
Factors to consider:
- Total employees count: 1570 (-7.6%) as of 2026
- China accounted for 48.4% of revenue in the fiscal year ended 2024-12-28
- US accounted for 10.7% of revenue in the fiscal year ended 2024-12-28
- Top business risk factors: Geopolitical risks, Regulatory and compliance, Supply chain disruptions, Market competition, Cybersecurity threats
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-01-03 to 2028-01-03
- 2026-01-03 to 2027-01-03 estimated range: [15.03$, 26.99$]
- 2027-01-03 to 2028-01-03 estimated range: [14.76$, 26.12$]
Financial Metrics affecting the USNA estimates:
- Positive: with PPE of 10.3 at the end of fiscal year the price was neutral
- Positive: 0.56 < Operating profit margin, % of 4.05
- Positive: 4.90 < Operating cash flow per share per price, % of 6.10
- Negative: Investing cash flow per share per price, % of -2.76 <= -2.60
- Positive: -4.55 < Industry operating profit margin (median), % of -0.43
- Negative: -0.33 < Industry inventory ratio change (median), % of -0.06
- Negative: Industry operating cash flow per share per price (median), % of 3.35 <= 3.66
- Negative: 1.34 < Inventory ratio change, % of 3.66
Short-term USNA quotes
Long-term USNA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-28 | 2026-01-03 |
|---|---|---|---|
| Operating Revenue | $921.01MM | $854.50MM | $925.26MM |
| Operating Expenses | $827.94MM | $788.18MM | $887.83MM |
| Operating Income | $93.07MM | $66.32MM | $37.43MM |
| Non-Operating Income | $9.38MM | $10.03MM | $4.09MM |
| Interest Expense | $0.26MM | $0.28MM | $0.84MM |
| R&D Expense | $11.45MM | $0.00MM | $0.00MM |
| Income(Loss) | $102.45MM | $76.35MM | $41.53MM |
| Taxes | $38.66MM | $34.29MM | $30.05MM |
| Net Income(Loss)* | $63.79MM | $42.03MM | $10.04MM |
| Stockholders Equity | $497.20MM | $532.11MM | $533.10MM |
| Inventory | $61.45MM | $69.73MM | $102.61MM |
| Assets | $632.76MM | $748.19MM | $742.91MM |
| Operating Cash Flow | $70.64MM | $60.99MM | $22.35MM |
| Capital expenditure | $14.49MM | $10.07MM | $13.82MM |
| Investing Cash Flow | $-11.97MM | $-213.09MM | $-10.12MM |
| Financing Cash Flow | $-14.24MM | $9.55MM | $-40.60MM |
| Earnings Per Share** | $3.31 | $2.20 | $0.54 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.